Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Clin Pharmacol Ther. 2019 May 31;106(4):821–830. doi: 10.1002/cpt.1464

Table 3:

Comparison of Model Estimates Between TDF and TAF

Parameter (TDF vs TAF) TDF TAF TAF Fraction (%)

TFV CL/F from BP (L/hr) 40.4 4.60* 11.3%
TFVdp elimination from PBMCs (hr−1) 0.0309 0.0124 40.1%
(K40 vs K30)
Transit of TFV from BP to SP (hr−1) 0.0152 0.00947 62.3%
(K25 vs K46)
Elimination of TFV from the SP (hr−1) 0.0126 1.98 15,700%
(K50 vs K60)
*

=based on a fixed TFV volume of distribution of 2000 L